Publication | Open Access
Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based Chemotherapy
49
Citations
25
References
2016
Year
Five independent prognostic factors in patients with recurrent or metastatic pancreatic cancer who received gemcitabine-based chemotherapy were identified. These findings may be helpful in prediction of prognosis in clinical practice and can be used as a stratification factor for clinical trials.
| Year | Citations | |
|---|---|---|
2015 | 27.2K | |
2010 | 11.5K | |
2011 | 7.6K | |
2013 | 6.5K | |
1997 | 5.8K | |
2007 | 3.8K | |
2002 | 3.1K | |
2013 | 2.5K | |
2008 | 2.1K | |
2015 | 1.2K |
Page 1
Page 1